Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03446131 · ClinicalTrials.gov registry record
Improved Training Program for Fall Prevention of War Fighters
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 45
- Enrollment target
NCT03446131: Completed study, sponsored by Mayo Clinic.
NCT03446131 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03446131 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
This study will train War Fighters with lower extremity trauma to decrease fall risk.
Primary Outcome
Trunk Position (referenced to vertical) at recovery step completion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2018-03-12 |
| Est. Completion | 2020-12-31 |
What the finished NCT03446131 record still lists
NCT03446131 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03446131 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03446131 about?
NCT03446131 is a clinical study titled "Improved Training Program for Fall Prevention of War Fighters". This study will train War Fighters with lower extremity trauma to decrease fall risk.
What is the current status of trial NCT03446131?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2018-03-12. Estimated completion is 2020-12-31.
Who is sponsoring clinical trial NCT03446131?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI